Nancy L. Edgehouse

CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.

M. Nagabhushan, Charles M. Miller, Theresa P. Pretlow et al. · PubMed · 1996 · 239 citations

Medicine, Oncology, Urology +14

CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma.

Mark A. Wainstein, Fei He, Dan R. Robinson et al. · PubMed · 1994 · 225 citations

Medicine, Molecular Biology, Oncology +14

Prostate cancer and other xenografts from cells in peripheral blood of patients.

Thomas G. Pretlow, Stuart Schwartz, Joseph M. Giaconia et al. · PubMed · 2000 · 38 citations

Medicine, Cancer Biology, Oncology +13

Differential experimental micrometastasis to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma cells

Julianne L. Holleran, Carson J. Miller, Nancy L. Edgehouse et al. · Clinical & Experimental Metastasis · 2002 · 20 citations

Medicine, Molecular Biology, Oncology +14

Molecular cytogenetic studies of a serially transplanted primary prostatic carcinoma xenograft (CWR22) and four relapsed tumors

M Kochera, Theresa W. Depinet, Theresa P. Pretlow et al. · The Prostate · 1999 · 14 citations

Life Sciences, Molecular Biology, Oncology +14